nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—glaucoma	0.677	1	CbGaD
Salicylate-sodium—Acetylsalicylic acid—TP53—glaucoma	0.00266	0.464	CrCbGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00128	0.1	CbGpPWpGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00102	0.0797	CbGpPWpGaD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000876	0.0685	CbGpPWpGaD
Salicylate-sodium—Magnesium salicylate—PTGS2—glaucoma	0.00082	0.143	CrCbGaD
Salicylate-sodium—Salsalate—PTGS2—glaucoma	0.000697	0.122	CrCbGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.000695	0.0544	CbGpPWpGaD
Salicylate-sodium—Mesalazine—PTGS2—glaucoma	0.000605	0.106	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—glaucoma	0.000521	0.0908	CrCbGaD
Salicylate-sodium—Salicylic acid—PTGS2—glaucoma	0.000429	0.0748	CrCbGaD
Salicylate-sodium—Asthma—Timolol—glaucoma	0.000352	0.00116	CcSEcCtD
Salicylate-sodium—Fatigue—Acetazolamide—glaucoma	0.000351	0.00115	CcSEcCtD
Salicylate-sodium—Paraesthesia—Brimonidine—glaucoma	0.000351	0.00115	CcSEcCtD
Salicylate-sodium—Infection—Pilocarpine—glaucoma	0.000351	0.00115	CcSEcCtD
Salicylate-sodium—Nausea—Methazolamide—glaucoma	0.00035	0.00115	CcSEcCtD
Salicylate-sodium—Hypotension—Dorzolamide—glaucoma	0.000349	0.00115	CcSEcCtD
Salicylate-sodium—Dyspnoea—Brimonidine—glaucoma	0.000349	0.00115	CcSEcCtD
Salicylate-sodium—Somnolence—Brimonidine—glaucoma	0.000348	0.00114	CcSEcCtD
Salicylate-sodium—Hypotension—Travoprost—glaucoma	0.000347	0.00114	CcSEcCtD
Salicylate-sodium—Shock—Pilocarpine—glaucoma	0.000347	0.00114	CcSEcCtD
Salicylate-sodium—Bronchospasm—Timolol—glaucoma	0.000347	0.00114	CcSEcCtD
Salicylate-sodium—Erythema—Clonidine—glaucoma	0.000345	0.00113	CcSEcCtD
Salicylate-sodium—Tachycardia—Pilocarpine—glaucoma	0.000344	0.00113	CcSEcCtD
Salicylate-sodium—Dyspepsia—Brimonidine—glaucoma	0.000344	0.00113	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Betaxolol—glaucoma	0.000344	0.00113	CcSEcCtD
Salicylate-sodium—Hallucination—Betaxolol—glaucoma	0.000344	0.00113	CcSEcCtD
Salicylate-sodium—Hypotension—Brinzolamide—glaucoma	0.000343	0.00113	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Pilocarpine—glaucoma	0.000341	0.00112	CcSEcCtD
Salicylate-sodium—Fatigue—Brimonidine—glaucoma	0.000337	0.00111	CcSEcCtD
Salicylate-sodium—Anorexia—Pilocarpine—glaucoma	0.000336	0.00111	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Acetazolamide—glaucoma	0.000336	0.0011	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Apraclonidine—glaucoma	0.000336	0.0011	CcSEcCtD
Salicylate-sodium—Paraesthesia—Dorzolamide—glaucoma	0.000335	0.0011	CcSEcCtD
Salicylate-sodium—Pain—Brimonidine—glaucoma	0.000334	0.0011	CcSEcCtD
Salicylate-sodium—Dyspnoea—Dorzolamide—glaucoma	0.000333	0.00109	CcSEcCtD
Salicylate-sodium—Somnolence—Dorzolamide—glaucoma	0.000332	0.00109	CcSEcCtD
Salicylate-sodium—Dyspnoea—Travoprost—glaucoma	0.000331	0.00109	CcSEcCtD
Salicylate-sodium—Hypotension—Pilocarpine—glaucoma	0.00033	0.00108	CcSEcCtD
Salicylate-sodium—Paraesthesia—Brinzolamide—glaucoma	0.00033	0.00108	CcSEcCtD
Salicylate-sodium—Dyspepsia—Dorzolamide—glaucoma	0.000329	0.00108	CcSEcCtD
Salicylate-sodium—Dyspnoea—Brinzolamide—glaucoma	0.000327	0.00108	CcSEcCtD
Salicylate-sodium—Dyspepsia—Travoprost—glaucoma	0.000327	0.00108	CcSEcCtD
Salicylate-sodium—Asthenia—Apraclonidine—glaucoma	0.000327	0.00107	CcSEcCtD
Salicylate-sodium—Somnolence—Brinzolamide—glaucoma	0.000326	0.00107	CcSEcCtD
Salicylate-sodium—Vision blurred—Clonidine—glaucoma	0.000325	0.00107	CcSEcCtD
Salicylate-sodium—Decreased appetite—Dorzolamide—glaucoma	0.000325	0.00107	CcSEcCtD
Salicylate-sodium—Urticaria—Acetazolamide—glaucoma	0.000324	0.00106	CcSEcCtD
Salicylate-sodium—Dyspepsia—Brinzolamide—glaucoma	0.000323	0.00106	CcSEcCtD
Salicylate-sodium—Pruritus—Apraclonidine—glaucoma	0.000322	0.00106	CcSEcCtD
Salicylate-sodium—Body temperature increased—Acetazolamide—glaucoma	0.000322	0.00106	CcSEcCtD
Salicylate-sodium—Fatigue—Dorzolamide—glaucoma	0.000322	0.00106	CcSEcCtD
Salicylate-sodium—Tinnitus—Betaxolol—glaucoma	0.000322	0.00106	CcSEcCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—FN1—glaucoma	0.000322	0.0252	CbGpPWpGaD
Salicylate-sodium—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.000321	0.0251	CbGpPWpGaD
Salicylate-sodium—Fatigue—Travoprost—glaucoma	0.000321	0.00105	CcSEcCtD
Salicylate-sodium—Pain—Dorzolamide—glaucoma	0.000319	0.00105	CcSEcCtD
Salicylate-sodium—Decreased appetite—Brinzolamide—glaucoma	0.000319	0.00105	CcSEcCtD
Salicylate-sodium—Pain—Travoprost—glaucoma	0.000318	0.00105	CcSEcCtD
Salicylate-sodium—Constipation—Travoprost—glaucoma	0.000318	0.00105	CcSEcCtD
Salicylate-sodium—Paraesthesia—Pilocarpine—glaucoma	0.000317	0.00104	CcSEcCtD
Salicylate-sodium—Asthenia—Bimatoprost—glaucoma	0.000317	0.00104	CcSEcCtD
Salicylate-sodium—Fatigue—Brinzolamide—glaucoma	0.000316	0.00104	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CA1—glaucoma	0.000315	0.0247	CbGpPWpGaD
Salicylate-sodium—Dyspnoea—Pilocarpine—glaucoma	0.000315	0.00103	CcSEcCtD
Salicylate-sodium—Pain—Brinzolamide—glaucoma	0.000314	0.00103	CcSEcCtD
Salicylate-sodium—Somnolence—Pilocarpine—glaucoma	0.000314	0.00103	CcSEcCtD
Salicylate-sodium—Pruritus—Bimatoprost—glaucoma	0.000312	0.00103	CcSEcCtD
Salicylate-sodium—Diarrhoea—Apraclonidine—glaucoma	0.000312	0.00102	CcSEcCtD
Salicylate-sodium—Dyspepsia—Pilocarpine—glaucoma	0.000311	0.00102	CcSEcCtD
Salicylate-sodium—Syncope—Clonidine—glaucoma	0.00031	0.00102	CcSEcCtD
Salicylate-sodium—Arrhythmia—Betaxolol—glaucoma	0.000308	0.00101	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Dorzolamide—glaucoma	0.000308	0.00101	CcSEcCtD
Salicylate-sodium—Decreased appetite—Pilocarpine—glaucoma	0.000307	0.00101	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Travoprost—glaucoma	0.000306	0.00101	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Dorzolamide—glaucoma	0.000305	0.001	CcSEcCtD
Salicylate-sodium—Palpitations—Clonidine—glaucoma	0.000305	0.001	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Travoprost—glaucoma	0.000304	0.000999	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Clonidine—glaucoma	0.000303	0.000997	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Brinzolamide—glaucoma	0.000302	0.000994	CcSEcCtD
Salicylate-sodium—Pain—Pilocarpine—glaucoma	0.000302	0.000992	CcSEcCtD
Salicylate-sodium—Constipation—Pilocarpine—glaucoma	0.000302	0.000992	CcSEcCtD
Salicylate-sodium—Dizziness—Apraclonidine—glaucoma	0.000301	0.00099	CcSEcCtD
Salicylate-sodium—Erythema—Betaxolol—glaucoma	0.000301	0.000988	CcSEcCtD
Salicylate-sodium—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—glaucoma	0.000299	0.0234	CbGpPWpGaD
Salicylate-sodium—Urticaria—Dorzolamide—glaucoma	0.000297	0.000975	CcSEcCtD
Salicylate-sodium—Epistaxis—Timolol—glaucoma	0.000296	0.000974	CcSEcCtD
Salicylate-sodium—Abdominal pain—Dorzolamide—glaucoma	0.000295	0.00097	CcSEcCtD
Salicylate-sodium—Body temperature increased—Dorzolamide—glaucoma	0.000295	0.00097	CcSEcCtD
Salicylate-sodium—Dysgeusia—Betaxolol—glaucoma	0.000294	0.000968	CcSEcCtD
Salicylate-sodium—Chest pain—Clonidine—glaucoma	0.000294	0.000966	CcSEcCtD
Salicylate-sodium—Abdominal pain—Travoprost—glaucoma	0.000294	0.000966	CcSEcCtD
Salicylate-sodium—Anxiety—Clonidine—glaucoma	0.000293	0.000963	CcSEcCtD
Salicylate-sodium—Asthenia—Acetazolamide—glaucoma	0.000292	0.000961	CcSEcCtD
Salicylate-sodium—Dizziness—Bimatoprost—glaucoma	0.000292	0.00096	CcSEcCtD
Salicylate-sodium—Urticaria—Brinzolamide—glaucoma	0.000292	0.000959	CcSEcCtD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000291	0.0228	CbGpPWpGaD
Salicylate-sodium—Feeling abnormal—Pilocarpine—glaucoma	0.000291	0.000956	CcSEcCtD
Salicylate-sodium—Vomiting—Apraclonidine—glaucoma	0.00029	0.000952	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Pilocarpine—glaucoma	0.000288	0.000948	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Brimonidine—glaucoma	0.000288	0.000947	CcSEcCtD
Salicylate-sodium—Dermatitis—Apraclonidine—glaucoma	0.000287	0.000943	CcSEcCtD
Salicylate-sodium—Headache—Apraclonidine—glaucoma	0.000285	0.000938	CcSEcCtD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000284	0.0222	CbGpPWpGaD
Salicylate-sodium—Confusional state—Clonidine—glaucoma	0.000284	0.000934	CcSEcCtD
Salicylate-sodium—Vision blurred—Betaxolol—glaucoma	0.000283	0.000931	CcSEcCtD
Salicylate-sodium—Oedema—Clonidine—glaucoma	0.000282	0.000926	CcSEcCtD
Salicylate-sodium—Hallucination—Timolol—glaucoma	0.000281	0.000923	CcSEcCtD
Salicylate-sodium—Asthenia—Brimonidine—glaucoma	0.000281	0.000922	CcSEcCtD
Salicylate-sodium—Infection—Clonidine—glaucoma	0.00028	0.00092	CcSEcCtD
Salicylate-sodium—Abdominal pain—Pilocarpine—glaucoma	0.000279	0.000917	CcSEcCtD
Salicylate-sodium—Body temperature increased—Pilocarpine—glaucoma	0.000279	0.000917	CcSEcCtD
Salicylate-sodium—Diarrhoea—Acetazolamide—glaucoma	0.000279	0.000916	CcSEcCtD
Salicylate-sodium—Rash—Bimatoprost—glaucoma	0.000278	0.000915	CcSEcCtD
Salicylate-sodium—Dermatitis—Bimatoprost—glaucoma	0.000278	0.000914	CcSEcCtD
Salicylate-sodium—Shock—Clonidine—glaucoma	0.000277	0.000911	CcSEcCtD
Salicylate-sodium—Pruritus—Brimonidine—glaucoma	0.000277	0.000909	CcSEcCtD
Salicylate-sodium—Headache—Bimatoprost—glaucoma	0.000277	0.000909	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Dorzolamide—glaucoma	0.000275	0.000904	CcSEcCtD
Salicylate-sodium—Tachycardia—Clonidine—glaucoma	0.000275	0.000904	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Travoprost—glaucoma	0.000274	0.0009	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Clonidine—glaucoma	0.000272	0.000895	CcSEcCtD
Salicylate-sodium—Nausea—Apraclonidine—glaucoma	0.00027	0.000889	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Brinzolamide—glaucoma	0.00027	0.000889	CcSEcCtD
Salicylate-sodium—Syncope—Betaxolol—glaucoma	0.00027	0.000886	CcSEcCtD
Salicylate-sodium—Dizziness—Acetazolamide—glaucoma	0.000269	0.000886	CcSEcCtD
Salicylate-sodium—Anorexia—Clonidine—glaucoma	0.000269	0.000883	CcSEcCtD
Salicylate-sodium—Asthenia—Dorzolamide—glaucoma	0.000268	0.000881	CcSEcCtD
Salicylate-sodium—Asthenia—Travoprost—glaucoma	0.000267	0.000877	CcSEcCtD
Salicylate-sodium—Palpitations—Betaxolol—glaucoma	0.000266	0.000873	CcSEcCtD
Salicylate-sodium—Pruritus—Dorzolamide—glaucoma	0.000264	0.000868	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Betaxolol—glaucoma	0.000264	0.000868	CcSEcCtD
Salicylate-sodium—Asthenia—Brinzolamide—glaucoma	0.000263	0.000866	CcSEcCtD
Salicylate-sodium—Hypotension—Clonidine—glaucoma	0.000263	0.000865	CcSEcCtD
Salicylate-sodium—Pruritus—Travoprost—glaucoma	0.000263	0.000865	CcSEcCtD
Salicylate-sodium—Tinnitus—Timolol—glaucoma	0.000263	0.000864	CcSEcCtD
Salicylate-sodium—Nausea—Bimatoprost—glaucoma	0.000262	0.000862	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Pilocarpine—glaucoma	0.00026	0.000854	CcSEcCtD
Salicylate-sodium—Pruritus—Brinzolamide—glaucoma	0.00026	0.000854	CcSEcCtD
Salicylate-sodium—Vomiting—Acetazolamide—glaucoma	0.000259	0.000851	CcSEcCtD
Salicylate-sodium—Dizziness—Brimonidine—glaucoma	0.000259	0.00085	CcSEcCtD
Salicylate-sodium—Chest pain—Betaxolol—glaucoma	0.000256	0.000841	CcSEcCtD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—FN1—glaucoma	0.000255	0.02	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Dorzolamide—glaucoma	0.000255	0.00084	CcSEcCtD
Salicylate-sodium—Headache—Acetazolamide—glaucoma	0.000255	0.000839	CcSEcCtD
Salicylate-sodium—Anxiety—Betaxolol—glaucoma	0.000255	0.000838	CcSEcCtD
Salicylate-sodium—Diarrhoea—Travoprost—glaucoma	0.000254	0.000836	CcSEcCtD
Salicylate-sodium—Asthenia—Pilocarpine—glaucoma	0.000253	0.000832	CcSEcCtD
Salicylate-sodium—Paraesthesia—Clonidine—glaucoma	0.000253	0.000832	CcSEcCtD
Salicylate-sodium—Arrhythmia—Timolol—glaucoma	0.000252	0.000828	CcSEcCtD
Salicylate-sodium—Dyspnoea—Clonidine—glaucoma	0.000251	0.000826	CcSEcCtD
Salicylate-sodium—Diarrhoea—Brinzolamide—glaucoma	0.000251	0.000826	CcSEcCtD
Salicylate-sodium—Somnolence—Clonidine—glaucoma	0.00025	0.000823	CcSEcCtD
Salicylate-sodium—Pruritus—Pilocarpine—glaucoma	0.00025	0.000821	CcSEcCtD
Salicylate-sodium—Confusional state—Betaxolol—glaucoma	0.000247	0.000813	CcSEcCtD
Salicylate-sodium—Dizziness—Dorzolamide—glaucoma	0.000247	0.000812	CcSEcCtD
Salicylate-sodium—Rash—Brimonidine—glaucoma	0.000247	0.00081	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—TXN—glaucoma	0.000246	0.0193	CbGpPWpGaD
Salicylate-sodium—Dermatitis—Brimonidine—glaucoma	0.000246	0.00081	CcSEcCtD
Salicylate-sodium—Dizziness—Travoprost—glaucoma	0.000246	0.000808	CcSEcCtD
Salicylate-sodium—Erythema—Timolol—glaucoma	0.000246	0.000807	CcSEcCtD
Salicylate-sodium—Oedema—Betaxolol—glaucoma	0.000245	0.000806	CcSEcCtD
Salicylate-sodium—Headache—Brimonidine—glaucoma	0.000245	0.000805	CcSEcCtD
Salicylate-sodium—Decreased appetite—Clonidine—glaucoma	0.000245	0.000805	CcSEcCtD
Salicylate-sodium—Infection—Betaxolol—glaucoma	0.000244	0.000801	CcSEcCtD
Salicylate-sodium—Fatigue—Clonidine—glaucoma	0.000243	0.000799	CcSEcCtD
Salicylate-sodium—Dizziness—Brinzolamide—glaucoma	0.000243	0.000798	CcSEcCtD
Salicylate-sodium—Nausea—Acetazolamide—glaucoma	0.000242	0.000795	CcSEcCtD
Salicylate-sodium—Diarrhoea—Pilocarpine—glaucoma	0.000241	0.000794	CcSEcCtD
Salicylate-sodium—Shock—Betaxolol—glaucoma	0.000241	0.000793	CcSEcCtD
Salicylate-sodium—Pain—Clonidine—glaucoma	0.000241	0.000792	CcSEcCtD
Salicylate-sodium—Constipation—Clonidine—glaucoma	0.000241	0.000792	CcSEcCtD
Salicylate-sodium—Dysgeusia—Timolol—glaucoma	0.00024	0.00079	CcSEcCtD
Salicylate-sodium—Tachycardia—Betaxolol—glaucoma	0.000239	0.000787	CcSEcCtD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000239	0.0187	CbGpPWpGaD
Salicylate-sodium—Vomiting—Dorzolamide—glaucoma	0.000237	0.00078	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Betaxolol—glaucoma	0.000237	0.00078	CcSEcCtD
Salicylate-sodium—Rash—Dorzolamide—glaucoma	0.000235	0.000774	CcSEcCtD
Salicylate-sodium—Dermatitis—Dorzolamide—glaucoma	0.000235	0.000773	CcSEcCtD
Salicylate-sodium—Rash—Travoprost—glaucoma	0.000234	0.000771	CcSEcCtD
Salicylate-sodium—Dermatitis—Travoprost—glaucoma	0.000234	0.00077	CcSEcCtD
Salicylate-sodium—Headache—Dorzolamide—glaucoma	0.000234	0.000769	CcSEcCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—PTGS2—glaucoma	0.000234	0.0183	CbGpPWpGaD
Salicylate-sodium—Anorexia—Betaxolol—glaucoma	0.000234	0.000769	CcSEcCtD
Salicylate-sodium—Vomiting—Brinzolamide—glaucoma	0.000233	0.000767	CcSEcCtD
Salicylate-sodium—Dizziness—Pilocarpine—glaucoma	0.000233	0.000767	CcSEcCtD
Salicylate-sodium—Headache—Travoprost—glaucoma	0.000233	0.000766	CcSEcCtD
Salicylate-sodium—Nausea—Brimonidine—glaucoma	0.000232	0.000763	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Clonidine—glaucoma	0.000232	0.000763	CcSEcCtD
Salicylate-sodium—Rash—Brinzolamide—glaucoma	0.000231	0.000761	CcSEcCtD
Salicylate-sodium—Vision blurred—Timolol—glaucoma	0.000231	0.000761	CcSEcCtD
Salicylate-sodium—Dermatitis—Brinzolamide—glaucoma	0.000231	0.00076	CcSEcCtD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000231	0.0181	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Clonidine—glaucoma	0.00023	0.000757	CcSEcCtD
Salicylate-sodium—Headache—Brinzolamide—glaucoma	0.00023	0.000756	CcSEcCtD
Salicylate-sodium—Hypotension—Betaxolol—glaucoma	0.000229	0.000753	CcSEcCtD
Salicylate-sodium—Vomiting—Pilocarpine—glaucoma	0.000224	0.000737	CcSEcCtD
Salicylate-sodium—Urticaria—Clonidine—glaucoma	0.000224	0.000736	CcSEcCtD
Salicylate-sodium—Body temperature increased—Clonidine—glaucoma	0.000223	0.000732	CcSEcCtD
Salicylate-sodium—Abdominal pain—Clonidine—glaucoma	0.000223	0.000732	CcSEcCtD
Salicylate-sodium—Rash—Pilocarpine—glaucoma	0.000222	0.000731	CcSEcCtD
Salicylate-sodium—Dermatitis—Pilocarpine—glaucoma	0.000222	0.000731	CcSEcCtD
Salicylate-sodium—Nausea—Dorzolamide—glaucoma	0.000222	0.000729	CcSEcCtD
Salicylate-sodium—Headache—Pilocarpine—glaucoma	0.000221	0.000727	CcSEcCtD
Salicylate-sodium—Nausea—Travoprost—glaucoma	0.000221	0.000726	CcSEcCtD
Salicylate-sodium—Paraesthesia—Betaxolol—glaucoma	0.00022	0.000724	CcSEcCtD
Salicylate-sodium—Syncope—Timolol—glaucoma	0.00022	0.000724	CcSEcCtD
Salicylate-sodium—Dyspnoea—Betaxolol—glaucoma	0.000219	0.000719	CcSEcCtD
Salicylate-sodium—Nausea—Brinzolamide—glaucoma	0.000218	0.000717	CcSEcCtD
Salicylate-sodium—Palpitations—Timolol—glaucoma	0.000217	0.000713	CcSEcCtD
Salicylate-sodium—Dyspepsia—Betaxolol—glaucoma	0.000216	0.00071	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Timolol—glaucoma	0.000216	0.000709	CcSEcCtD
Salicylate-sodium—Decreased appetite—Betaxolol—glaucoma	0.000213	0.000701	CcSEcCtD
Salicylate-sodium—Fatigue—Betaxolol—glaucoma	0.000211	0.000695	CcSEcCtD
Salicylate-sodium—Pain—Betaxolol—glaucoma	0.00021	0.00069	CcSEcCtD
Salicylate-sodium—Constipation—Betaxolol—glaucoma	0.00021	0.00069	CcSEcCtD
Salicylate-sodium—Nausea—Pilocarpine—glaucoma	0.00021	0.000689	CcSEcCtD
Salicylate-sodium—Chest pain—Timolol—glaucoma	0.000209	0.000687	CcSEcCtD
Salicylate-sodium—Anxiety—Timolol—glaucoma	0.000208	0.000685	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Clonidine—glaucoma	0.000208	0.000682	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000203	0.0159	CbGpPWpGaD
Salicylate-sodium—Asthenia—Clonidine—glaucoma	0.000202	0.000665	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Betaxolol—glaucoma	0.000202	0.000664	CcSEcCtD
Salicylate-sodium—Confusional state—Timolol—glaucoma	0.000202	0.000664	CcSEcCtD
Salicylate-sodium—Oedema—Timolol—glaucoma	0.0002	0.000659	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Timolol—glaucoma	0.0002	0.000659	CcSEcCtD
Salicylate-sodium—Pruritus—Clonidine—glaucoma	0.000199	0.000655	CcSEcCtD
Salicylate-sodium—Infection—Timolol—glaucoma	0.000199	0.000654	CcSEcCtD
Salicylate-sodium—Shock—Timolol—glaucoma	0.000197	0.000648	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—TXN—glaucoma	0.000196	0.0153	CbGpPWpGaD
Salicylate-sodium—Urticaria—Betaxolol—glaucoma	0.000195	0.000641	CcSEcCtD
Salicylate-sodium—PTGS1—Eicosanoid Synthesis—PTGS2—glaucoma	0.000194	0.0152	CbGpPWpGaD
Salicylate-sodium—Body temperature increased—Betaxolol—glaucoma	0.000194	0.000637	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Timolol—glaucoma	0.000194	0.000637	CcSEcCtD
Salicylate-sodium—Diarrhoea—Clonidine—glaucoma	0.000193	0.000634	CcSEcCtD
Salicylate-sodium—Anorexia—Timolol—glaucoma	0.000191	0.000628	CcSEcCtD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.00019	0.0149	CbGpPWpGaD
Salicylate-sodium—Hypotension—Timolol—glaucoma	0.000187	0.000616	CcSEcCtD
Salicylate-sodium—Dizziness—Clonidine—glaucoma	0.000186	0.000612	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Betaxolol—glaucoma	0.000181	0.000594	CcSEcCtD
Salicylate-sodium—Paraesthesia—Timolol—glaucoma	0.00018	0.000591	CcSEcCtD
Salicylate-sodium—Vomiting—Clonidine—glaucoma	0.000179	0.000589	CcSEcCtD
Salicylate-sodium—Dyspnoea—Timolol—glaucoma	0.000179	0.000587	CcSEcCtD
Salicylate-sodium—Somnolence—Timolol—glaucoma	0.000178	0.000586	CcSEcCtD
Salicylate-sodium—Rash—Clonidine—glaucoma	0.000178	0.000584	CcSEcCtD
Salicylate-sodium—Dermatitis—Clonidine—glaucoma	0.000177	0.000583	CcSEcCtD
Salicylate-sodium—Headache—Clonidine—glaucoma	0.000177	0.00058	CcSEcCtD
Salicylate-sodium—Dyspepsia—Timolol—glaucoma	0.000176	0.00058	CcSEcCtD
Salicylate-sodium—Asthenia—Betaxolol—glaucoma	0.000176	0.000579	CcSEcCtD
Salicylate-sodium—Decreased appetite—Timolol—glaucoma	0.000174	0.000573	CcSEcCtD
Salicylate-sodium—PTGS2—Spinal Cord Injury—C1QB—glaucoma	0.000174	0.0136	CbGpPWpGaD
Salicylate-sodium—Pruritus—Betaxolol—glaucoma	0.000174	0.00057	CcSEcCtD
Salicylate-sodium—Fatigue—Timolol—glaucoma	0.000173	0.000568	CcSEcCtD
Salicylate-sodium—Pain—Timolol—glaucoma	0.000171	0.000563	CcSEcCtD
Salicylate-sodium—Diarrhoea—Betaxolol—glaucoma	0.000168	0.000552	CcSEcCtD
Salicylate-sodium—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000168	0.0131	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000168	0.0131	CbGpPWpGaD
Salicylate-sodium—Nausea—Clonidine—glaucoma	0.000167	0.00055	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Timolol—glaucoma	0.000165	0.000543	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Timolol—glaucoma	0.000164	0.000539	CcSEcCtD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000162	0.0127	CbGpPWpGaD
Salicylate-sodium—Dizziness—Betaxolol—glaucoma	0.000162	0.000533	CcSEcCtD
Salicylate-sodium—Urticaria—Timolol—glaucoma	0.000159	0.000523	CcSEcCtD
Salicylate-sodium—Body temperature increased—Timolol—glaucoma	0.000158	0.000521	CcSEcCtD
Salicylate-sodium—Abdominal pain—Timolol—glaucoma	0.000158	0.000521	CcSEcCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—TNF—glaucoma	0.000158	0.0124	CbGpPWpGaD
Salicylate-sodium—Vomiting—Betaxolol—glaucoma	0.000156	0.000513	CcSEcCtD
Salicylate-sodium—Rash—Betaxolol—glaucoma	0.000155	0.000508	CcSEcCtD
Salicylate-sodium—Dermatitis—Betaxolol—glaucoma	0.000155	0.000508	CcSEcCtD
Salicylate-sodium—Headache—Betaxolol—glaucoma	0.000154	0.000505	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—ABCA1—glaucoma	0.000152	0.0119	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Timolol—glaucoma	0.000148	0.000485	CcSEcCtD
Salicylate-sodium—PTGS2—S1P1 pathway—VEGFA—glaucoma	0.000146	0.0114	CbGpPWpGaD
Salicylate-sodium—Nausea—Betaxolol—glaucoma	0.000146	0.000479	CcSEcCtD
Salicylate-sodium—Asthenia—Timolol—glaucoma	0.000144	0.000473	CcSEcCtD
Salicylate-sodium—Pruritus—Timolol—glaucoma	0.000142	0.000466	CcSEcCtD
Salicylate-sodium—Diarrhoea—Timolol—glaucoma	0.000137	0.000451	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—SOD1—glaucoma	0.000136	0.0106	CbGpPWpGaD
Salicylate-sodium—Dizziness—Timolol—glaucoma	0.000133	0.000436	CcSEcCtD
Salicylate-sodium—Vomiting—Timolol—glaucoma	0.000127	0.000419	CcSEcCtD
Salicylate-sodium—Rash—Timolol—glaucoma	0.000126	0.000415	CcSEcCtD
Salicylate-sodium—Dermatitis—Timolol—glaucoma	0.000126	0.000415	CcSEcCtD
Salicylate-sodium—Headache—Timolol—glaucoma	0.000126	0.000413	CcSEcCtD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—TNF—glaucoma	0.000125	0.00981	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ABCA1—glaucoma	0.000121	0.00946	CbGpPWpGaD
Salicylate-sodium—Nausea—Timolol—glaucoma	0.000119	0.000391	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—GSTT1—glaucoma	0.000112	0.00875	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—PTGS2—glaucoma	0.000108	0.00844	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—SOD1—glaucoma	0.000108	0.00843	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—MTHFR—glaucoma	0.000108	0.00842	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—GSTM1—glaucoma	0.0001	0.00785	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—NGFR—glaucoma	9.2e-05	0.0072	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—CYP1B1—glaucoma	8.9e-05	0.00697	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	8.67e-05	0.00678	CbGpPWpGaD
Salicylate-sodium—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—glaucoma	8.62e-05	0.00674	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—MTHFR—glaucoma	8.54e-05	0.00668	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	8.32e-05	0.00651	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—BDNF—glaucoma	8e-05	0.00626	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	7.97e-05	0.00624	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CA5A—glaucoma	7.83e-05	0.00613	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NARFL—glaucoma	7.83e-05	0.00613	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL1A—glaucoma	7.68e-05	0.00601	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	7.21e-05	0.00564	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—GSTM1—glaucoma	7.12e-05	0.00557	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—PTGS2—glaucoma	6.86e-05	0.00537	CbGpPWpGaD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	6.78e-05	0.0053	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.6e-05	0.00517	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NARFL—glaucoma	6.22e-05	0.00487	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CA5A—glaucoma	6.22e-05	0.00487	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—TNF—glaucoma	6.18e-05	0.00483	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CDKN2A—glaucoma	6.05e-05	0.00473	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	5.95e-05	0.00465	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—glaucoma	5.78e-05	0.00452	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LRP12—glaucoma	5.63e-05	0.0044	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	5.48e-05	0.00429	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	5.44e-05	0.00426	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CDKN1B—glaucoma	5.35e-05	0.00419	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	4.66e-05	0.00365	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—TNF—glaucoma	4.63e-05	0.00362	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CDKN1B—glaucoma	4.08e-05	0.00319	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	3.98e-05	0.00312	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CA1—glaucoma	3.83e-05	0.00299	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MMP9—glaucoma	3.78e-05	0.00296	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CTSA—glaucoma	3.7e-05	0.0029	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—TNF—glaucoma	3.68e-05	0.00288	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGFR1OP—glaucoma	3.63e-05	0.00284	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HEYL—glaucoma	3.63e-05	0.00284	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CA2—glaucoma	3.5e-05	0.00274	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.42e-05	0.00268	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.42e-05	0.00268	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CA1—glaucoma	3.04e-05	0.00238	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CTSA—glaucoma	2.94e-05	0.0023	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TNF—glaucoma	2.91e-05	0.00228	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CA2—glaucoma	2.78e-05	0.00217	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.77e-05	0.00217	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.71e-05	0.00212	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.71e-05	0.00212	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TP53—glaucoma	2.56e-05	0.00201	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TXN—glaucoma	2.47e-05	0.00193	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	2.31e-05	0.00181	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HDAC9—glaucoma	2.26e-05	0.00177	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.25e-05	0.00176	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.23e-05	0.00174	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.98e-05	0.00155	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TXN—glaucoma	1.96e-05	0.00153	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTT1—glaucoma	1.91e-05	0.0015	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.79e-05	0.0014	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.77e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.74e-05	0.00136	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.54e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCA1—glaucoma	1.52e-05	0.00119	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP1B1—glaucoma	1.52e-05	0.00119	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTT1—glaucoma	1.52e-05	0.00119	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTM1—glaucoma	1.22e-05	0.000953	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN2B—glaucoma	1.22e-05	0.000952	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCA1—glaucoma	1.21e-05	0.000946	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP1B1—glaucoma	1.21e-05	0.000946	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTHFR—glaucoma	1.08e-05	0.000842	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTHFR—glaucoma	1.02e-05	0.000798	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APOE—glaucoma	1e-05	0.000784	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CAV1—glaucoma	9.92e-06	0.000777	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTM1—glaucoma	9.66e-06	0.000756	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APOE—glaucoma	9.5e-06	0.000743	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CAV1—glaucoma	9.41e-06	0.000736	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—BAD—glaucoma	8.85e-06	0.000692	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTHFR—glaucoma	8.54e-06	0.000668	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APOE—glaucoma	7.95e-06	0.000622	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CAV1—glaucoma	7.88e-06	0.000617	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NOS3—glaucoma	7.5e-06	0.000587	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS3—glaucoma	7.11e-06	0.000557	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTGS2—glaucoma	6.86e-06	0.000537	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN1B—glaucoma	6.16e-06	0.000482	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NOS3—glaucoma	5.96e-06	0.000466	CbGpPWpGaD
